Region Sjælland Due Diligence
Run due diligence on Region Sjælland: check compliance and get alerts when suppliers or ownership change.
Denmark · owned by Independent (Denmark) · regionsjaelland.dk · 10 vendors
Region Sjælland is one of Denmark's five administrative regions, responsible for operating hospitals, psychiatric services, and social institutions across the Zealand region. It also manages tasks related to regional development, traffic, environment, and raw materials. The region serves the population of Zealand with a budget of approximately 18 billion Danish kroner annually.
Resilience scores
- Digital Sovereignty: 30
- Digital Resilience: 7
- Financial Resilience: 8
Technology vendors
- Barracuda Networks, Inc. — Cybersecurity — United States
- GMO GlobalSign K.K. — Technology — Japan
- HR-ON A/S — Technology — Denmark
- and 7 more
Services catalogue
3 services in catalogue across 3 categories; runs on 10 sub-vendors.
- AI model training and testing
- Clinical co-development
- Extensions
Insights
Last updated 2026-09-13 · revision 8
10 direct vendors, 128 subvendors
Direct vendors by controlling owner country (sample)
- United States: 6
- Denmark: 3
- Japan: 1
Subvendors by controlling owner country (sample)
- Portugal: 1
- Netherlands: 2
- United Kingdom: 2
Compliance
9 in-scope frameworks identified; showing 3.
NIS2 (source) — No public evidence
Evidence: https://www.regionsjaelland.dk/servicemenu/om-os/organisation/koncern-digitalisering, https://www.regionsjaelland.dk/servicemenu/om-os/strategier/digitaliseringsstrategi, https://www.regionsjaelland.dk/servicemenu/om-os/persondatapolitik/persondatapolitik-og-regionens-dpo, https://www.regionsjaelland.dk
Danish Accessibility Requirements — Evidence found
Evidence: https://www.was.digst.dk/regionsjaelland-dk, https://www.regionsjaelland.dk/servicemenu/om-os/om-hjemmesiden/tilgaengelighedserklaering
Danish Health Act — No public evidence
Evidence: https://www.regionsjaelland.dk/sundhed/patientrettigheder-og-vejledning, https://www.regionsjaelland.dk/servicemenu/om-os/om-region-sjaelland/region-sjaellands-hovedopgaver, https://www.regionsjaelland.dk
Financials
Three-year financials
- 2026: revenue DKK 25.8B, equity DKK -558.5M
- 2025: revenue DKK 23.1B
- 2024: revenue DKK 22.4B
Financial Resilience Score: 8/10
Region Sjælland is a Danish statutory regional authority, not a private company, and therefore benefits from sovereign backing. It cannot legally go bankrupt, and its funding is dominated by the Danish state block grant (bloktilskud) plus municipal activity-based co-financing, which together represent over 99% of its revenue base. Annual budgets are set via the national Økonomiaftale between the state and Danske Regioner, providing high predictability and inflation-adjusted growth (income grew 3.3% in 2025 and 3.8% in 2026). With a 2026 operating budget of ~DKK 25.8 billion, over 17,000 employees, and a diversified public-service base (hospitals, psychiatry, social institutions, regional development, transport), the entity has substantial scale and operational resilience. A DKK 50 million buffer reserve is maintained in the 2026 budget as an unexpected-expenditure cushion. However, significant structural and operational risks reduce the score from a maximum. The 2027 merger with Region Hovedstaden into Region Østdanmark introduces major organizational, IT, HR, and financial-integration risks, with DKK 50.2 million earmarked in 2026 for transition costs. Region Sjælland also has the lowest doctor-density in Denmark despite high patient needs, faces rising medicine and diabetes-technology costs, and has a documented deficit at Sjællands Universitetshospital that required action plans in 2024–25. The new University Hospital in Køge has also required a DKK 275 million framework increase due to material-cost inflation, and 2026 opening liquid assets are budgeted at DKK -257 million. Accounting-based equity is negative (DKK -558.5M) but this reflects Danish public-sector accounting conventions (donations, revaluations, provisions), not economic distress.
Key strengths: Sovereign-backed funding model with ~85% state block grant, Statutory entity — cannot legally go bankrupt, Large, diversified public-service base (DKK 25.8B budget, >17,000 employees), Predictable annual funding via Økonomiaftale, DKK 50M buffer reserve in 2026 budget, Break-even social area financed by municipalities
Risk factors: 2027 merger with Region Hovedstaden into Region Østdanmark (integration risk), Lowest doctor-per-capita ratio in Denmark, Rising specialist medicine and diabetes-technology costs, Collective transport (Movia) financing pressures in outer years, Regional Udvikling block grant reduced DKK 23M in 2026, DKK 275M cost overrun on new Køge University Hospital, Deficit at Sjællands Universitetshospital requiring action plans, Negative 2026 opening liquid assets (DKK -257M)
Revenue by geography
- Denmark (Zealand region): 100%
Revenue by product/service
- Sundhed (Healthcare): 93%
- Social & Specialundervisning: 5%
- Regional Udvikling: 2%
Workforce by country
- Denmark: 17000
Signed-in users can see whether their own company is exposed to this vendor's disruption, plus the full sub-vendor list and country breakdowns, every in-scope compliance framework plus gaps and next steps, and alerts when any of it changes.